Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-11-14 5:05 pm Purchase | 13G | AEON BIOPHARMA INC AEON | Blue Owl Capital Holdings LP | 3,341,204 8.450% | 3,341,204 (New Position) | View |
| 2024-02-14 1:46 pm Purchase | 13G | AEON BIOPHARMA INC AEON | Polar Asset Management Partners Inc. | 3,675,000 9.900% | 3,675,000 (New Position) | View |
| 2024-02-14 09:00 am Unchanged | 13G | AEON BIOPHARMA INC AEON | Empyrean Capital Partners LP | 0 0.000% | 0 (Unchanged) | View |
| 2023-08-22 4:37 pm Sale | 13D | AEON BIOPHARMA INC AEON | Strathspey Crown Holdings Group LLC | 2,031,773 5.470% | -7,388,597 (-78.43%) | View |
| 2023-07-31 4:45 pm Purchase | 13D | AEON BIOPHARMA INC AEON | Strathspey Crown Holdings Group LLC | 9,420,370 25.400% | 9,420,370 (New Position) | View |
| 2023-07-31 4:15 pm Purchase | 13G | AEON BIOPHARMA INC AEON | Atalaya Capital Management LP | 3,675,000 9.890% | 3,675,000 (New Position) | View |
| 2023-07-28 07:55 am Purchase | 13D | AEON BIOPHARMA INC AEON | Daewoong Co. Ltd | 6,577,604 23.980% | 6,577,604 (New Position) | View |
| 2023-07-20 11:32 am Unchanged | 13G | AEON BIOPHARMA INC AEON | Saba Capital Management L.P. | 0 0.000% | 0 (Unchanged) | View |
| 2023-06-12 4:42 pm Sale | 13G | AEON BIOPHARMA INC AEON | GLAZER CAPITAL LLC | 59,166 2.950% | -168,378 (-74.00%) | View |
| 2023-03-10 4:33 pm Purchase | 13G | AEON BIOPHARMA INC AEON | GLAZER CAPITAL LLC | 227,544 11.360% | 227,544 (New Position) | View |
| 2021-02-22 08:30 am Purchase | 13G | AEON BIOPHARMA INC AEON | Empyrean Capital Partners LP | 1,400,000 5.100% | 1,400,000 (New Position) | View |